4.7 Article

Fibroin nanoparticles: a promising drug delivery system

Journal

DRUG DELIVERY
Volume 27, Issue 1, Pages 431-448

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/10717544.2020.1736208

Keywords

Fibroin; nanoparticles; biomaterial; review; administrative route

Funding

  1. National Research Council of Thailand (NRCT) under the Royal Golden Jubilee (RGJ-ASEAN) [PHD/0234/2560]
  2. Naresuan University [R2561B009]
  3. Naresuan University Scholarship
  4. Naresuan University Scholarship for Oral Presentation
  5. RGJASEAN Grant

Ask authors/readers for more resources

Fibroin is a dominant silk protein that possesses ideal properties as a biomaterial for drug delivery. Recently, the development of fibroin nanoparticles (FNPs) for various biomedical applications has been extensively studied. Due to their versatility and chemical modifiability, FNPs can encapsulate different types of therapeutic compounds, including small and big molecules, proteins, enzymes, vaccines, and genetic materials. Moreover, FNPs are able to be administered both parenterally and non-parenterally. This review summaries basic information on the silk and fibroin origin and characteristics, followed by the up-to-date data on the FNPs preparation and characterization methods. In addition, their medical applications as a drug delivery system are in-depth explored based on several administrative routes of parenteral, oral, transdermal, ocular, orthopedic, and respiratory. Finally, the challenges and suggested solutions, as well as the future outlooks of these systems are discussed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available